Evaluation of different ways to identify persistent positivity of lupus anticoagulant in systemic lupus erythematosus [PDF]
Lupus Science and Medicine, 2020 Objective Persistent positivity for lupus anticoagulant has been associated with an increased risk of thrombosis among patients with SLE. Persistent positivity is often defined as having two positive assessments separated by more than 90 days.
Laurence S Magder, Mertcan Avci
doaj +2 more sources
Exogenous Magnesium Chloride Reduces the Activated Partial Thromboplastin Times of Lupus Anticoagulant-Positive Patients. [PDF]
PLoS ONE, 2016 The activated partial thromboplastin time (APTT) assay is a basic hemostatic assay based on the time it takes for clots to form in plasma samples after the addition of calcium chloride. It is used to screen for various coagulation disorders.
Takayoshi Tokutake +10 more
doaj +3 more sources
Lupus anticoagulant hypoprothrombinemia syndrome: A case report [PDF]
Clinical Case Reports, 2023 Lupus anticoagulant hypoprothrombinemia syndrome (LAHPS) is a rare entity associated with an increased risk of hemorrhage. Corticosteroids have been used in its treatment with favorable results.
Natalia Acedo +5 more
doaj +2 more sources
Successful treatment of lupus anticoagulant hypoprothrombinemia syndrome with rituximab [PDF]
Thrombosis Journal, 2023 Lupus anticoagulant-hypoprothrombinemia syndrome (LAHPS) is a rare acquired bleeding disorder secondary to development of antibodies against prothrombin protein, in the presence of antiphospholipid antibodies.
Sanober Nusrat +2 more
doaj +2 more sources
Lupus anticoagulant associated with low grade B-cell lymphoma and IgM paraproteinaemia with lupus cofactor phenomenon on DRVVT and SCT assays - a possible novel association [PDF]
Thrombosis JournalBackground Lupus anticoagulant (LA) is an in vitro phenomenon with prolongation of a phospholipid-dependent coagulation test which is not due to an inhibitor specific to a coagulation factor.
Ting Hon Stanford Li +4 more
doaj +2 more sources
Clinical features and treatment of 70 children with lupus anticoagulant-hypoprothrombinemia syndrome: a retrospective study from a single center in China [PDF]
Research and Practice in Thrombosis and HaemostasisBackground: Lupus anticoagulant-hypoprothrombinemia syndrome (LAHPS) is a rare acquired bleeding disorder characterized by the presence of lupus anticoagulant (LA) and acquired hypoprothrombinemia.
Dandan Tian +9 more
doaj +2 more sources
Journal of Marine Medical SocietyBackground: Antiphospholipid antibodies (aPL), a heterogeneous group of circulating antibodies including lupus anticoagulant (LAC), anticardiolipin antibodies (aCL), & anti-beta-2-glycoprotein 1 antibodies (aβ2GP1) that have been associated with ...
Blessy Mathew +5 more
doaj +2 more sources
Acquired hemophilia A in the setting of dual anticoagulation therapy and lupus anticoagulant: a case report [PDF]
Journal of Medical Case Reports, 2022 Background Acquired hemophilia A is a disorder caused by autoantibodies against coagulation factor VIII that may present with severe bleeding. We report a rare case of acquired hemophilia A presenting with coexisting lupus anticoagulant.
Victor Chen +4 more
doaj +2 more sources
Prognostic Value of Lupus Anticoagulant and Anti-β2 Glycoprotein I Antibody in Adverse Pregnancy Outcomes. [PDF]
Arthritis RheumatolNonobe M +8 more
europepmc +3 more sources